APA (7th ed.) Citation

H, L., Y, M., S, H., H, C., S, S., J, K., . . . K, K. (2026). Low-dose radiation generated ROS-activatable doxorubicin prodrug loaded liposome nanoparticles for triple-negative breast cancer treatment. Journal of controlled release : official journal of the Controlled Release Society, 393, 114750. https://doi.org/10.1016/j.jconrel.2026.114750

Chicago Style (17th ed.) Citation

H, Lim, et al. "Low-dose Radiation Generated ROS-activatable Doxorubicin Prodrug Loaded Liposome Nanoparticles for Triple-negative Breast Cancer Treatment." Journal of Controlled Release : Official Journal of the Controlled Release Society 393 (2026): 114750. https://doi.org/10.1016/j.jconrel.2026.114750.

MLA (9th ed.) Citation

H, Lim, et al. "Low-dose Radiation Generated ROS-activatable Doxorubicin Prodrug Loaded Liposome Nanoparticles for Triple-negative Breast Cancer Treatment." Journal of Controlled Release : Official Journal of the Controlled Release Society, vol. 393, 2026, p. 114750, https://doi.org/10.1016/j.jconrel.2026.114750.

Warning: These citations may not always be 100% accurate.